UNSPSC 85541845: Inspection of cisterna chyli, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to inspection of cisterna chyli, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07JL3ZZ

UNSPSC 85541845 Inspection of cisterna chyli, percutaneous approach is a Commodity code with no recent state and local procurement activity directly aligned to its nominal medical procedure scope. The six recent opportunities posted between July and September 2026 that are tagged to this code—independent medical evaluations for disability pension determinations, surgical benefit carve-outs for health plans, occupational medical surveillance, emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—do not involve lymphatic vessel inspection or percutaneous diagnostic procedures. The code's abstract definition does not match the actual work state and local buyers are conducting under it in current practice.

This mismatch suggests either a taxonomy classification error at the point of solicitation or that the code has drifted from its intended scope in state and local procurement systems. Issuers include a municipal retirement office (City of Phoenix), city procurement departments (Long Beach, Collier County), a state transportation agency (Washington State Department of Transportation), a county juvenile justice department (Harris County), and regional health systems (Santa Clara County Health System). Geographic activity spans Arizona, California, Florida, Texas, and Washington. Given the disconnect between the code's clinical specificity and the administrative and occupational health services actually being solicited, vendors pursuing work under this code should verify the code assignment with each issuing body before bid preparation, as the posted opportunities suggest classification inconsistency rather than a market signal for percutaneous lymphatic diagnostics.